PharmaBoardroom

Interview with Bram Bout, Chief Executive Officer, Bioceros B.V.

Bioceros was founded as a service company built on the immunology expertise of its founders. Additional cell line expertise was added when you joined…

Interview with Tse-Ming, Pang, Managing Director, Emerging…

Since its origin, Emerging Pharma has been helping foreign pharma companies to enter Malaysia. However, the Malaysian market is relatively small. Why…

Interview with Gennady Shirshov, Executive Director, Union of…

Last time Focus Reports met with you in 2006, the Russian pharmaceutical industry had enjoyed five straight years of growth. This growth has since…

Interview with Dr. Hasit Joshipura, Vice President, South asia…

A catalyst of India’s shifting industry dynamics has been the sector’s M&A activity. We already saw majors such as Piramal going to…

Interview with Sunil Parekh, Industry Expert, Sunil Parekh

With the recent event “Vibrant Gujarat”, the state of Gujarat aimed to showcase the region’s opportunities and advanced infrastructure, hosting…

Interview with Chris Gilbert, Russia Director Russo-British…

There is a long history of trade between Russia and Britain. The Chamber of Commerce started in 1916. Can you outline how the organisation has evolved…

Interview with Dato’ Noharuddin Nordin , CEO, Malaysia External…

How would you describe the operating environment for foreign companies to use the services of Malaysian companies and how can you reassure these…

Interview with Smitesh Shah, Chairman & Managing Director,…

You founded Calyx in 1979 with a three-person team. At the time, you were just 21 years old! What was the vision behind the creation of the company?…

Interview with Murtaza Khorakiwala, Managing Director, Wockhardt

You joined Wockhardt in 2000; you became a member of the board in 2006, and were appointed managing director in 2009. The Indian industry has…

Interview: Glenn Saldanha, Managing Director & CEO, Glenmark

Glenmark may be poised to release India’s first novel drug, from the in-licensed, anti-diarrheal molecule Crofelemer. Crofelemer has successfully…

Interview with Jan Egberts, CEO, OctoPlus N.V.

Clearly the end of 2010 was an exciting time for you. As you entered the transition period as the new CEO of OctoPlus, you also participated in the…

Interview with Benno van Dongen, Partner, Roland Berger Strategy…

As the founder of the Institute of Young Entrepreneurs at the Delft University of Technology and an enthusiastic promoter of innovation and new…

Tagged with